Anti Mullerian Hormone (AMH): Introduction
- The anti-Müllerian hormone (AMH) is a glycoprotein-based hormone that is used to determine fertility levels
- The anti-Mullerian hormone (AMH) test measures the level of anti-müllerian hormone (AMH) in the blood. AMH is produced in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on the patient’s age and gender.
- In females, the roles of the AMH have been the focus of recent attention. AMH plays an important role in the development of sex organs in an unborn baby. In women, the anti-Müllerian hormone test is employed to assess ovarian function and menopausal status; in the evaluation of polycystic ovary syndrome (PCOS) or to evaluate the effectiveness of ovarian cancer treatment. The AMH test is also used to evaluate the presence of external sex organs that are not clearly male or female infants (ambiguous genitalia) and/or function of the testicles in an infant boy.
Key Drivers and Restraints of Global Anti Mullerian Hormone (AMH) testing Market
- Presently, women have come a long way in terms of their careers and social standing. However, a majority of them are still unaware about their personal well-being and health needs. Government initiatives have changed the entire scenario.
- On October 18, 2014, the International IMS Society celebrated 'World Menopause Day' with the theme 'Prevention of diseases after menopause'. Rise in initiatives toward women’s education and awareness about their health is likely to generate high demand for diagnostic products including AMH testing.
- Incidence of women’s health diseases is increasing across the world. According to the Global Burden of Disease Study 2013 (GBD 2013), acute and chronic diseases and injuries occurred in 188 countries between 1990 and 2013 showed the following results: For uterine fibroid, 105,090 (*1000) cases were observed in 1990. The number increased to 171,005 (*1000) in 2013. Moreover, for polycystic ovarian syndrome, the number of cases increased from 80,815 in 1990 to 122,311 (*1000) in 2013.
Polycystic Ovary Syndrome (PCOS) Evaluation to Lead Global Market
- The global anti-Mullerian hormone (AMH) testing market can be segmented based on application, end-user, and region
- In terms of application, the global anti-Mullerian hormone (AMH) testing market can be divided into ovarian function, menopausal status, evaluation of polycystic ovary syndrome (PCOS), ovarian cancer treatment, and others
- Based on end-user, the global anti-Mullerian hormone (AMH) testing market can be categorized into hospitals, diagnostic laboratories, and others
Asia Pacific to be Lucrative Market
- The global anti-Mullerian hormone (AMH) testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominates the global-anti Mullerian hormone (AMH) testing market. Advancements in diagnostics, rise in awareness about effective use of AMH testing, and favorable reimbursement policies are key factors that make North America a highly attractive market among all regions. Asia Pacific is a highly populated region in the world. This offers significant opportunities for market players to expand their business in the region. Hence, existing global as well as local and regional players have a great scope to focus on this region in order to expand their business.
Key Players Operating in Global Anti Mullerian Hormone (AMH) testing Market
Leading players in the global anti-Mullerian hormone (AMH) testing market are:
- Danaher Corporation
- Becton, Dickinson and Company
Global Anti Mullerian Hormone (AMH) testing Market: Research Scope
Global Anti Mullerian Hormone (AMH) testing Market, by Application
- Ovarian Function
- Menopausal Status
- Evaluation Of Polycystic Ovary Syndrome (PCOS)
- Ovarian Cancer Treatment
Global Anti Mullerian Hormone (AMH) testing Market, by End-user
- Diagnostic Laboratories
Global Anti Mullerian Hormone (AMH) testing Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa